00634nas a2200265   4500000000100000008004100001260001300042653001200055653003100067653003000098653001300128653001100141653001400152653001000166653002300176653001200199653002500211653001500236100001300251245003200264856004100296300001000337490000700347022001400354       2000                            d  c2000 Sep10aDapsone10aDrug Resistance, Microbial10aDrug Therapy, Combination10aEthiopia10aHumans10aIncidence10aIndia10aLeprostatic Agents10aleprosy10aMycobacterium leprae10aPrevalence1 aHarboe M00aLeprosy at a turning point?  uhttp://ila.ilsl.br/pdfs/v68n3a10.pdf  a312-80 v68  a0148-916X